• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pathol Res Pract . RNase in the saliva can affect the detection of severe acute respiratory syndrome coronavirus 2 by real-time one-step polymerase

tetano

Editor, Senior Moderator
Pathol Res Pract


. 2021 Feb 16;220:153381.
doi: 10.1016/j.prp.2021.153381. Online ahead of print.
RNase in the saliva can affect the detection of severe acute respiratory syndrome coronavirus 2 by real-time one-step polymerase chain reaction using saliva samples


Yuka Nishibata[SUP] 1 [/SUP], Shota Koshimoto[SUP] 1 [/SUP], Kenta Ogaki[SUP] 1 [/SUP], Erika Ishikawa[SUP] 1 [/SUP], Kosuke Wada[SUP] 1 [/SUP], Miku Yoshinari[SUP] 1 [/SUP], Yuto Tamura[SUP] 1 [/SUP], Ryo Uozumi[SUP] 1 [/SUP], Sakiko Masuda[SUP] 1 [/SUP], Utano Tomaru[SUP] 2 [/SUP], Akihiro Ishizu[SUP] 3 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus that causes coronavirus disease 2019, which spread worldwide immediately after the first patient infected with this virus was discovered in Wuhan, China, in December 2019. Currently, polymerase chain reaction (PCR) specimens for the detection of SARS-CoV-2 include saliva, nasopharyngeal swabs, and lower respiratory tract-derived materials such as sputum. Initially, nasopharyngeal swab specimens were applied mainly to the PCR detection of SARS-CoV-2. There was a risk of infection to healthcare workers due to coughing or sneezing by the subjects at the time of sample collection. In contrast, saliva specimens have a low risk of droplet infection and are easy to collect, and their application to PCR testing has been promoted. In this study, we have determined the detection limit of SARS-CoV-2 in saliva samples and examined the effects of storage temperature and storage time of saliva samples on the PCR detection results. As a result, 5 ? 10[SUP]3[/SUP] copies of SARS-CoV-2 could be detected in 1 mL phosphate-buffered saline, whereas 5 ? 10[SUP]4[/SUP] copies of SARS-CoV-2 were needed in 1 mL saliva to detect the virus by real-time one-step PCR. Interestingly, SARS-CoV-2 (5 ? 10[SUP]3[/SUP] copies/mL) could be detected in saliva supplemented with an RNase inhibitor. Concerning the saliva samples supplemented with an RNase inhibitor, the optimal temperature for sample storage was -20 ?C, and PCR detection was maintained within 48 h without problems under these conditions. These finding suggest that RNase in the saliva can affect the detection of SARS-CoV-2 by PCR using saliva samples.

Keywords: COVID-19; PCR; RNase; SARS-CoV-2; Saliva.
 
Back
Top Bottom